Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
5076
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.37M | ﹤0.01% |
404,615
+346,366
| +595% | +$1.01M |
|
|
HSKA
5077
DELISTED
Heska Corp
HSKA
| $1.37M | ﹤0.01% |
14,684
-33,248
| -69% | -$2.56M |
|
|
HAPN
5078
Happen Inc
HAPN
$2.26B
| $1.37M | ﹤0.01% |
300,484
+161,968
| +117% | +$1.01M |
|
5079
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$78M
| $1.37M | ﹤0.01% |
26,771
-19,021
| -42% | -$910K |
|
|
ZUO
5080
PUT
DELISTED
Zuora, Inc.
ZUO
| $1.37M | ﹤0.01% |
107,200
+11,600
| +12% | +$129K |
|
5081
Invesco Short Term Treasury ETF
TBLL
$2.85B
| $1.36M | ﹤0.01% |
12,902
-6,226
| -33% | -$659K |
|
5082
The Greenbrier Companies
GBX
$1.41B
| $1.36M | ﹤0.01% |
59,980
-35,899
| -37% | -$698K |
|
5083
Liberty Latin America Class A
LILA
$1.69B
| $1.36M | ﹤0.01% |
219,265
+57,248
| +35% | +$376K |
|
5084
Open Text
OTEX
$5.94B
| $1.36M | ﹤0.01% |
32,114
-44,170
| -58% | -$1.75M |
|
5085
PUT
United States 12 Month Oil Fund,
USL
$45.7M
| $1.36M | ﹤0.01% |
+92,400
| New | +$1.19M |
|
5086
PUT
XP
XP
$8.17B
| $1.36M | ﹤0.01% |
32,400
+8,300
| +34% | +$255K |
|
5087
Innovator US Equity Power Buffer ETF August
PAUG
$938M
| $1.36M | ﹤0.01% |
52,855
+9,375
| +22% | +$233K |
|
|
5088
CALL
United States 12 Month Oil Fund,
USL
$45.7M
| $1.36M | ﹤0.01% |
+92,200
| New | +$1.18M |
|
5089
CALL
DXP Enterprises
DXPE
$3.12B
| $1.36M | ﹤0.01% |
+68,200
| New | +$1.1M |
|
5090
Fossil Group
FOSL
$329M
| $1.36M | ﹤0.01% |
292,017
+180,683
| +162% | +$694K |
|
5091
PUT
Medpace
MEDP
$16.1B
| $1.36M | ﹤0.01% |
14,600
+700
| +5% | +$59.6K |
|
5092
CALL
Rogers Corp
ROG
$2.55B
| $1.36M | ﹤0.01% |
10,900
+4,000
| +58% | +$428K |
|
|
PMT
5093
CALL
PennyMac Mortgage Investment
PMT
$824M
| $1.36M | ﹤0.01% |
77,400
+10,900
| +16% | +$131K |
|
5094
CALL
Kartoon Studios
TOON
$37.4M
| $1.36M | ﹤0.01% |
+60,320
| New | +$1.08M |
|
5095
CALL
Invesco CurrencyShares Swiss Franc Trust
FXF
$395M
| $1.35M | ﹤0.01% |
14,000
+4,500
| +47% | +$429K |
|
|
5096
PUT
Invesco CurrencyShares Swiss Franc Trust
FXF
$395M
| $1.35M | ﹤0.01% |
14,000
+1,500
| +12% | +$143K |
|
5097
PUT
Urban Outfitters
URBN
$6.66B
| $1.35M | ﹤0.01% |
89,000
-23,000
| -21% | -$394K |
|
|
AXDX
5098
CALL
DELISTED
Accelerate Diagnostics
AXDX
| $1.35M | ﹤0.01% |
8,930
+7,040
| +372% | +$694K |
|
5099
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.42B
| $1.35M | ﹤0.01% |
21,658
+7,052
| +48% | +$404K |
|
|
ECHO
5100
EchoStar
ECHO
$26.7B
| $1.35M | ﹤0.01% |
48,342
-96,691
| -67% | -$2.94M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.